GB0523961D0 - The treatment of ophthalmic diseases - Google Patents

The treatment of ophthalmic diseases

Info

Publication number
GB0523961D0
GB0523961D0 GBGB0523961.1A GB0523961A GB0523961D0 GB 0523961 D0 GB0523961 D0 GB 0523961D0 GB 0523961 A GB0523961 A GB 0523961A GB 0523961 D0 GB0523961 D0 GB 0523961D0
Authority
GB
United Kingdom
Prior art keywords
treatment
ophthalmic diseases
ophthalmic
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0523961.1A
Other versions
GB2432526A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sosei R&D Ltd
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Priority to GB0523961A priority Critical patent/GB2432526A/en
Publication of GB0523961D0 publication Critical patent/GB0523961D0/en
Publication of GB2432526A publication Critical patent/GB2432526A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0523961A 2005-11-24 2005-11-24 Use of ifenprodil for the treatment of ophthalmic diseases Withdrawn GB2432526A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0523961A GB2432526A (en) 2005-11-24 2005-11-24 Use of ifenprodil for the treatment of ophthalmic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0523961A GB2432526A (en) 2005-11-24 2005-11-24 Use of ifenprodil for the treatment of ophthalmic diseases

Publications (2)

Publication Number Publication Date
GB0523961D0 true GB0523961D0 (en) 2006-01-04
GB2432526A GB2432526A (en) 2007-05-30

Family

ID=35601152

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0523961A Withdrawn GB2432526A (en) 2005-11-24 2005-11-24 Use of ifenprodil for the treatment of ophthalmic diseases

Country Status (1)

Country Link
GB (1) GB2432526A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011137363A1 (en) * 2010-04-30 2011-11-03 Allergan, Inc. Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
EP2793855B1 (en) * 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbiprofen formulations
WO2013095319A2 (en) * 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations of flurbiprofen and diacerein
US20140371318A1 (en) * 2011-12-23 2014-12-18 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally-disintegrating formulations of flurbiprofen
US20140336148A1 (en) * 2011-12-27 2014-11-13 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combinations of diacerein and non-steroidal inflammation drugs
EP2797583B1 (en) * 2011-12-27 2015-09-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined pharmaceutical formulation containing diacerein
EP2727587A1 (en) * 2012-10-30 2014-05-07 Pharnext Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
CN103007284A (en) * 2013-01-16 2013-04-03 闫莹 Application of HMGCoA reductase inhibitor in preparation of medicine used for treating xerophthalmia
WO2015063140A1 (en) 2013-10-30 2015-05-07 Pharnext Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
JPH08231400A (en) * 1995-02-24 1996-09-10 Rohto Pharmaceut Co Ltd Intraocular pressure-lowering agent containing ifenprodil as essential ingredient
WO1997018812A1 (en) * 1995-11-17 1997-05-29 Alcon Laboratories, Inc. Combination therapy for treating glaucoma
WO1997024123A1 (en) * 1996-01-02 1997-07-10 Synthelabo Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye

Also Published As

Publication number Publication date
GB2432526A (en) 2007-05-30

Similar Documents

Publication Publication Date Title
HK1215960A1 (en) Improved modalities for the treatment of degenerative diseases of the retina
HRP20150175T1 (en) Means and methods for the treatment of tumorous diseases
AP2006003671A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
HK1113797A1 (en) Quinoline derivative for the treatment of retinal diseases
IL191283A (en) Compositions for the treatment of ophthalmic disorders
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
SI2056863T1 (en) Treatment of ocular diseases
EP1962869A4 (en) Treatment of respiratory diseases
GB0523961D0 (en) The treatment of ophthalmic diseases
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
PL1904060T3 (en) Use of phthalocyanine derivates for the non-photodynamic treatment of diseases
GB0523964D0 (en) The treatment of ophthalmic diseases
EP1865952A4 (en) Histamine-containing composition for the treatment of allergic diseases
GB0519274D0 (en) The treatment of neurodegenerative diseases
EP1846013A4 (en) Treatment of skin diseases
ZA200606780B (en) Compounds for the treatment of diseases
GB0523962D0 (en) The treatment of ophthalmic diseases
GB0523965D0 (en) The treatment of ophthalmic diseases
GB0700755D0 (en) The Treatment of ophthalmic diseases
GB0407710D0 (en) Treatment of diseases
GB0406388D0 (en) Sulfonamide derivatives for the treatment of diseases
HK1096379A1 (en) Sulfonamide derivatives for the treatment of diseases
GB0406387D0 (en) Sulfonamide derivatives for the treatment of diseases

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)